Thousands tracked in Largest-Ever liver cancer bead therapy registry
NCT ID NCT02305459
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This registry followed over 1,000 liver cancer patients who received SIR-Spheres—tiny radioactive beads injected into the liver's blood supply to kill tumors. The goal was to see how this treatment is used in real hospitals and how it affects survival, side effects, and quality of life. No new treatment was tested; instead, researchers collected data from routine care to better understand the therapy's impact.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Yttrium-90 loaded SIR-Spheres microspheres (radioactive beads delivered via catheter to liver tumors)
- What this could lead to
- If successful, this registry could confirm how well SIR-Spheres works in everyday practice, potentially guiding better use of this therapy for liver cancer patients.
- What could go wrong
- This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may vary widely across patients and hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cardiovascular and Interventional Radiological Society of Europe
Vienna, 1010, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a tailored diet before surgery boost liver cancer recovery?
- Why are young people getting cancer? a massive study aims to find out.
- Quick MRI may outshine ultrasound for liver cancer detection
- Simple blood test could spot 8 cancers early using AI
- New platform aims to predict which cancer treatments will work
- Cancer treatment gets personal: MATCH trial tests Gene-Guided drugs